ProfileGDS4459 / ENSG00000159322
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 72% 66% 88% 73% 80% 81% 84% 85% 89% 85% 80% 84% 90% 71% 83% 81% 82% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 15.3772
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 25.0266
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 37.0988
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 45.4273
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 56.1280
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 66.2181
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 76.5784
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 86.7285
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 97.2489
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 106.685
GSM623474group B, liver allograft wedge biopsie placebo treatment 16.1380
GSM623475group B, liver allograft wedge biopsie placebo treatment 26.684
GSM623476group B, liver allograft wedge biopsie placebo treatment 37.2390
GSM623477group B, liver allograft wedge biopsie placebo treatment 45.2271
GSM623478group B, liver allograft wedge biopsie placebo treatment 56.683
GSM623479group B, liver allograft wedge biopsie placebo treatment 65.9681
GSM623480group B, liver allograft wedge biopsie placebo treatment 76.1782